Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders

Volume: 26, Issue: 4, Pages: 856 - 856
Published: Feb 6, 2021
Abstract
Coagulation disorders, endotheliopathy and inflammation are the most common hallmarks in SARS-CoV-2 infection, largely determining COVID-19’s outcome and severity. Dysfunctions of endothelial cells and platelets are tightly linked in contributing to the systemic inflammatory response that appears to be both a cause and a consequence of COVID-19-associated coagulation disorders and thrombotic events. Indeed, elevated levels of circulating...
Paper Details
Title
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders
Published Date
Feb 6, 2021
Journal
Volume
26
Issue
4
Pages
856 - 856
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.